April 17–22, 2026 · San Diego · 2418 items
← Next-generation ADCs: payload innovation
3 people · 4 posts · 1 abstract
Heat now 1·Peak in the comparable set 1 (Apr 22 09:00)·Change over 24h in the comparable set –·Participants now 1
Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.
| Drug / trial | Readout | Setting |
|---|---|---|
| AVA6103 / pan-RAS ADCAVA6103CLDN18 | Tricomplex pan-RAS as payload | Among the floor’s strongest ADC threads |
Curtis Rink, Tom Clough, Ellen Watts, Folake Orafidiya, Marine Houée, Sophie Brown, Victoria Juskaite, Gezim Lahu, Ruairidh Edwards, Karen Campbell, Dave Liebowitz, David Jones, Francis Wilson, Michelle Morrow
Read the abstract →Best news ever! AVA6103 includes ER+ metastatic breast cancer! A major step forward!
Congrats Avacta! This is fantastic news!